2,4-diaminopyridine has been researched along with Anaplastic Large-Cell Lymphoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bursulaya, B; Chen, B; Hood, T; Jiang, T; Jin, Y; Kim, S; Lee, C; Li, N; Liu, B; Lu, W; Marsilje, TH; Michellys, PY; Nguyen, TN; Pei, W; Steffy, A; Sun, F; Tuntland, T; Uno, T; Wu, B; Zhu, X | 1 |
1 other study(ies) available for 2,4-diaminopyridine and Anaplastic Large-Cell Lymphoma
Article | Year |
---|---|
Design and synthesis of novel selective anaplastic lymphoma kinase inhibitors.
Topics: 4-Aminopyridine; Anaplastic Lymphoma Kinase; Animals; Antineoplastic Agents; Binding Sites; Cell Line, Tumor; Crystallography, X-Ray; Drug Design; Half-Life; Humans; Lymphoma, Large-Cell, Anaplastic; Mice; Mice, SCID; Microsomes, Liver; Molecular Dynamics Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Rats; Receptor Protein-Tyrosine Kinases; Structure-Activity Relationship; Transplantation, Heterologous | 2016 |